Reaction
Ankle Operation reporting signals
As of the last recalculation, Ankle Operation appears in 1,443 FAERS reports alongside 22 co-occurring drug terms. The strongest observed disproportionality signal is ANAKINRA (PRR 50.6).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Anakinra | 56 | 50.6 | 50.8 |
| Calcium, Magnesium, Potassium, And Sodium Oxybates | 15 | 25.4 | 25.4 |
| Upadacitinib | 100 | 18.9 | 19.0 |
| Abatacept | 104 | 11.6 | 11.6 |
| Risankizumab-Rzaa | 59 | 10.8 | 10.8 |
| Bimekizumab | 15 | 10.3 | 10.3 |
| Sodium Oxybate | 42 | 9.4 | 9.4 |
| Armodafinil | 10 | 6.9 | 6.9 |
| Eptinezumab-Jjmr | 4 | 6.4 | 6.4 |
| Tofacitinib | 76 | 6.2 | 6.2 |
| Emicizumab | 5 | 5.9 | 5.9 |
| Certolizumab Pegol | 42 | 5.3 | 5.3 |
| Etanercept | 183 | 4.9 | 4.9 |
| Brivaracetam | 3 | 4.8 | 4.8 |
| Vilazodone Hydrochloride | 3 | 4.7 | 4.7 |
| Belimumab | 10 | 4.6 | 4.6 |
| Esketamine Hydrochloride | 5 | 4.1 | 4.1 |
| Sarilumab | 5 | 2.7 | 2.7 |
| Droxidopa | 3 | 2.0 | 2.0 |
| Dupilumab | 58 | 1.8 | 1.8 |
| Valbenazine | 3 | 1.7 | 1.7 |
| Copper | 3 | 1.0 | 1.0 |